A former official at the Centers for Disease Control and Prevention warns that funding cuts outlined in the proposed fiscal ...

Congress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they received 10 weeks ago that laid them off. Damage to their projects may ...

Former CDC officials warn that proposed fiscal 2026 budget cuts would slash funding by 54%, threatening critical health ...

President Donald Trump's budget proposal for fiscal year 2026 requests significant reductions to HIV prevention and ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.

Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in ...

In last week’s Supreme Court ruling, the justices allowed federal agencies to proceed with their reduction-in-force, or RIF, ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more t… ...